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Purpose/Objective: International research indicates that oncology 
care workers are exposed to a variety of unique occupational stressors 
that put them at significant risk of burnout. This has severe 
implications for job satisfaction, the retention of staff and arguably 
the quality of care cancer patients receive whilst on treatment. The 
current study aimed to obtain a national indication of stress 
associated with occupational stressors, burnout and job satisfaction 
within New Zealand (NZ) Radiation Therapy departments. Potential 
indicators of burnout and job satisfaction were explored, as well as 
job satisfaction initiatives. 
Materials and Methods: All staff currently practicing in the eight 
Radiation Therapy departments in NZ were invited to participate 
anonymously in a questionnaire hosted on SurveyMonkey via email. 
The questionnaire contained questions addressing participant 
characteristics, such as age, work experience and position. The 
Maslach Burnout Inventory (MBI) was incorporated in order to make 
direct comparisons with previously published studies, and scales 
measuring the intensity of stress associated with specific occupational 
stressors, stress reduction strategies and job satisfaction were 
included. Incomplete responses were excluded and a total of 171 (out 
of 349) complete responses were analysed with SPSS 19.  
Results: Of the 171 responses, 23 identified as oncologists (Os), 111 
identified as radiation therapists (RTs), 22 identified as radiation 
nurses (RNs) and 15 identified as radiation physicists (RPs).  
All participants, regardless of profession, reported high stress levels 
associated with both patient-centred and organisational stressors. 
Participants scored high in all three domains of burnout: emotional 
exhaustion, depersonalisation and personal accomplishment. 
Interestingly, although organisational stressors and emotional 
exhaustion predicted lower job satisfaction, patient stressors were 
associated with higher job satisfaction. Job satisfaction initiatives 
such as on-going education, mentoring and role extension were 
supported by many participants as was addressing organisational 
stressors, such as lack of recognition and support from management 
and unrealistic expectations and demands. 
Conclusions: Staff in NZ exhibit higher levels of burnout than MBI 
medical norms and international studies conducted in Europe, North 
America and Australia. In contrast to previous studies, indications of 
personal accomplishment and job satisfaction were incredibly high. In 
NZ staff in Radiation Therapy departments may be more at risk of 
compromising their wellbeing, compelled by the sense of personal 
accomplishment and satisfaction they derive from their chosen 
profession. 
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Purpose/Objective: Head and neck (HN) radiotherapy within the 
Danish Head and Neck Cancer Group (DAHANCA) has changed in the 
last decade from 3D conformal radiotherapy to exclusively intensity 
modulated radiation therapy (IMRT). The steep 3D dose gradients in 
IMRT call for a high geometric and dosimetric accuracy in the entire 
chain from treatment planning to treatment delivery. The purpose of 
the DAHANCA RT-QA group is to monitor the quality of the IMRT 
delivery at all six radiotherapy departments participating in DAHANCA 
protocols. The geometric and dosimetric accuracy of the IMRT delivery 
was verified by means of an external, independent dose audit. 
Materials and Methods: The M. D. Anderson Phantom Lab (MDAPL) of 
the M. D. Anderson Cancer Center provided each DAHANCA center 
with an anthropomorphic HN phantom equipped with Thermo-
luminescence Dosimeters (TLD) and radiochromic films [A. Molineu, 
IJROBP 2005]. At each center, the phantom went through the standard 
clinical treatment chain similar to an actual patient, i.e. CT scan, 
treatment planning, and treatment delivery including cone beam-CT 
or kV image setup. Three centers used sliding window IMRT technique, 
two centers used segmental step and shoot IMRT technique and one 
center used volumetric modulated arc therapy technique (VMAT). 
According to MDAPL, the treatment planning should follow RTOG 
protocols where at least 95 % of the target must receive the 
prescribed dose. The DAHANCA guidelines, which adheres to ICRU, 
states that at least 95 % of the prescribed dose should be delivered to 
the entire target.This difference made the dose planning non standard 
for the centers. The films were analysed by gamma evaluation and the 
TLD measured doses were compared to the doses reported by the 
planning systems. 
Results: All centers met the MDAPL pass criteria of 85 % with gamma 
criteria of 7 % and 4 mm. The average pass rate for axial and sagittal 
films were 99.6 % (range 99-100 %) and 99.2 % (97-100 %), 
respectively. Using a more strict gamma criteria of 3 % and 3 mm, the 
average pass rates for the axial and sagittal films were 93 % (86-99 %) 
and 89 % (83-96 %), respectively. The average ratio of the measured 
RCP TLD doses to reported doses was 0.99±0.016(1SD) across the 
centers. The average displacement of the steepest dose gradient 
between primary PTV and organ at risk was 0.7 mm (0-2 mm). 
Conclusions: All 6 centers in DAHANCA passed the external dose 
audit. The analyses showed a high correlation between treatment plan 
and treatment delivery, indicating high and consistent quality of the 
IMRT delivered in the DAHANCA centers. 
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Purpose/Objective: To assess efficacy of planning QA for the ART 
DECO trial (CRUK/10/018) and identify any significant differences 
between static (sIMRT) and rotational (rIMRT) forms of IMRT in the 
trial. 
Materials and Methods: A randomised multicentre accelerated 
radiotherapy study of dose escalated IMRT vs. standard dose IMRT in 
patients receiving treatment for locally advanced 
laryngeal/hypopharyngeal cancers (ART DECO) is currently recruiting. 
The experimental arm of 67.2Gy/28 fractions to the radical target 
(PTV1) and 56Gy/28 fractions to the elective target (PTV2) is being 
tested against a UK standard of 65Gy/30fractions to PTV1 and 
54Gy/30fractions to PTV2. 
As part of the UK RTTQA IMRT credentialing program, the QA team 
reviews a hypopharynx test case planned by the centre at the 
experimental dose level for each planning system and delivery 
technique used. Non-compliant or sub-optimal plans require 
resubmission. Evaluations have been carried out on PTVs edited back 
from the skin surface. Local CTV-PTV and OAR-PRV margins were 
used. 
Results: To date, there have been 32 protocol compliant hypopharynx 
submissions from 27 centres; 14 using rIMRT and 18 sIMRT. 
Table 1 shows differences between the initial and approved plans for 
each centre. PTV1 coverage improved based on all DVH criteria 
investigated. PTV1 D5% improved, whilst no change was seen in 
D2%.PTV2 showed a statistically significant improvement at D95% and no 
degradations. 
There was an overall increase in dose to the brainstem (BS) and spinal 
cord (SC) PRVs at theD1cm3 level, all approved plans were within the 
tolerance of 55Gy and 48Gy respectively. No statistically significant 
changes were seen in all other constraints. 74% of plans met the 24Gy 
contralateral mean dose constraint in their final submission. 
In terms of target coverage, sIMRT and rIMRT plans were comparable. 
There were statistically significant differences at the PTV1 D50%, D5% 
and D2%,with rIMRT techniques being lower on average by 0.2Gy 
(p=0.014), 0.8Gy (p<0.001)and 0.6Gy (p=0.009) respectively. BS Dmax 
and BS PRV D1cm3were the only OAR or PRV constraints showing 
statistically significant differences,being on average 5.0Gy (p=0.046) 
and 5.1Gy (p=0.026) lower in the rIMRT plans. 
